Adverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India.

<h4>Background</h4>Significant adverse events (AE) have been reported in patients receiving medications for multidrug- and extensively-drug-resistant tuberculosis (MDR-TB & XDR-TB). However, there is little prospective data on AE in MDR- or XDR-TB/HIV co-infected patients on antitube...

Full description

Bibliographic Details
Main Authors: Petros Isaakidis, Bhanumati Varghese, Homa Mansoor, Helen S Cox, Joanna Ladomirska, Peter Saranchuk, Esdras Da Silva, Samsuddin Khan, Roma Paryani, Zarir Udwadia, Giovanni Battista Migliori, Giovanni Sotgiu, Tony Reid
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22792406/?tool=EBI